Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3,975.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,825.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 2,009
  • Market Cap: £207.07m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
55.87% above the market average55.87% above the market average55.87% above the market average55.87% above the market average55.87% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
1yr Revenue Growth
49.49% above the market average49.49% above the market average49.49% above the market average49.49% above the market average49.49% above the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
13.19% below the market average13.19% below the market average13.19% below the market average13.19% below the market average13.19% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
1yr DPS Growth
43.01% above the market average43.01% above the market average43.01% above the market average43.01% above the market average43.01% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
41.29% above the market average41.29% above the market average41.29% above the market average41.29% above the market average41.29% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
Price Book Ratio
91.97% below the market average91.97% below the market average91.97% below the market average91.97% below the market average91.97% below the market average
70.83% below the sector average70.83% below the sector average70.83% below the sector average70.83% below the sector average70.83% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
36.74% below the market average36.74% below the market average36.74% below the market average36.74% below the market average36.74% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average
Price Chg 3m
28.47% below the market average28.47% below the market average28.47% below the market average28.47% below the market average28.47% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
15.53% below the market average15.53% below the market average15.53% below the market average15.53% below the market average15.53% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Momentum 20
97.76% below the market average97.76% below the market average97.76% below the market average97.76% below the market average97.76% below the market average
96.67% below the sector average96.67% below the sector average96.67% below the sector average96.67% below the sector average96.67% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
78.32% above the market average78.32% above the market average78.32% above the market average78.32% above the market average78.32% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
ROCE
79.33% above the market average79.33% above the market average79.33% above the market average79.33% above the market average79.33% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
93.53% above the market average93.53% above the market average93.53% above the market average93.53% above the market average93.53% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
33.58% below the market average33.58% below the market average33.58% below the market average33.58% below the market average33.58% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Operating Profit Loss
38.58% above the market average38.58% above the market average38.58% above the market average38.58% above the market average38.58% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
27.95% below the market average27.95% below the market average27.95% below the market average27.95% below the market average27.95% below the market average
23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average
Cash
9.51% below the market average9.51% below the market average9.51% below the market average9.51% below the market average9.51% below the market average
12% below the sector average12% below the sector average12% below the sector average12% below the sector average12% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,975.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4,500.00
52 Week Low 3,825.00
Volume 2,009
Shares Issued 5.21m
Market Cap £207.07m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.13% below the market average84.13% below the market average84.13% below the market average84.13% below the market average84.13% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
46.47% below the market average46.47% below the market average46.47% below the market average46.47% below the market average46.47% below the market average
25.81% below the sector average25.81% below the sector average25.81% below the sector average25.81% below the sector average25.81% below the sector average
Income Not Available
Growth
77.40% above the market average77.40% above the market average77.40% above the market average77.40% above the market average77.40% above the market average
Sector averageSector averageSector averageSector averageSector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 24-Sep-2021

Time Volume / Share Price
16:35 413 @ 3,974.76p
16:34 414 @ 3,974.76p
15:21 5 @ 3,975.00p
15:02 56 @ 4,000.00p
14:30 25 @ 3,975.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page